Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Belumosudil for Chronic Graft-Versus-Host Disease
Recruiting1 awardPhase 2
Saint Louis, Missouri
This trial tests the safety and effectiveness of a new drug for people with cGVHD who have had 2 prior treatments. Participation lasts up to 4 weeks and follow-up every 12 weeks.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service